One-year cardiovascular outcomes after coronavirus disease 2019: The cardiovascular COVID-19 registry.

ABSTRACT:

Background

The long-term cardiovascular (CV) outcomes of COVID-19 have not been fully explored.

Methods

This was an international, multicenter, retrospective cohort study conducted between February and December 2020. Consecutive patients ≥18 years who underwent a real-time reverse transcriptase-polymerase chain reaction (RT-PCR) for SARS-CoV2 were included. Patients were classified into two cohorts depending on the nasopharyngeal swab result and clinical status: confirmed COVID-19 (positive RT-PCR) and control (without suggestive symptoms and negative RT-PCR). Data were obtained from electronic records, and clinical follow-up was performed at 1-year. The primary outcome was CV death at 1-year. Secondary outcomes included arterial thrombotic events (ATE), venous thromboemboli

SUBMITTER: Ortega-Paz L 

PROVIDER: S-EPMC9803130 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature